291 related articles for article (PubMed ID: 1933900)
21. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
22. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
23. Loss of colonic HLA antigens in familial adenomatous polyposis.
Tsioulias G; Godwin TA; Goldstein MF; McDougall CJ; Ngoi SS; DeCosse JJ; Rigas B
Cancer Res; 1992 Jun; 52(12):3449-52. PubMed ID: 1317751
[TBL] [Abstract][Full Text] [Related]
24. Can the HLA phenotype be used as a prognostic factor in breast carcinomas?
Concha A; Cabrera T; Ruiz-Cabello F; Garrido F
Int J Cancer Suppl; 1991; 6():146-54. PubMed ID: 2066180
[TBL] [Abstract][Full Text] [Related]
25. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
[TBL] [Abstract][Full Text] [Related]
26. Expression of class II major histocompatibility complex molecules correlates with human colon tumor vaccine efficacy.
Ransom JH; Pelle B; Hanna MG
Cancer Res; 1992 Jun; 52(12):3460-6. PubMed ID: 1596903
[TBL] [Abstract][Full Text] [Related]
27. Reaction patterns of tumor infiltrating lymphocytes in different renal cell carcinomas and oncocytomas.
Störkel S; Keymer R; Steinbach F; Thoenes W
Prog Clin Biol Res; 1992; 378():217-23. PubMed ID: 1363795
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of five new human renal tumor xenografts.
Beniers AJ; Peelen WP; Schaafsma HE; Beck JL; Ramaekers FC; Debruyne FM; Schalken JA
Am J Pathol; 1992 Feb; 140(2):483-95. PubMed ID: 1739137
[TBL] [Abstract][Full Text] [Related]
29. MHC expression on human tumors--its relevance for local tumor growth and metastasis.
Garrido F; Ruiz-Cabello F
Semin Cancer Biol; 1991 Feb; 2(1):3-10. PubMed ID: 1912516
[TBL] [Abstract][Full Text] [Related]
30. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
31. MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21ras) levels in human breast tumors.
Solana R; Romero J; Alonso C; Peña J
Invasion Metastasis; 1992; 12(3-4):210-7. PubMed ID: 1294532
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic markers in renal cell carcinoma.
Banner BF; Burnham JA; Bahnson RR; Ernstoff MS; Auerbach HE
Mod Pathol; 1990 Mar; 3(2):129-34. PubMed ID: 1691492
[TBL] [Abstract][Full Text] [Related]
33. Metastasis formation in human solid tumors: phenotypic characteristics of early metastatic cells.
Riethmüller G; Schlimok G; Pantel K; Angstwurm M; Izbicki J; Karg O; Stade BG; Johnson JP
Behring Inst Mitt; 1992 Apr; (91):204-9. PubMed ID: 1355966
[No Abstract] [Full Text] [Related]
34. Serological analysis of the dissociation process of HLA-B and C class I molecules.
Gillet AC; Pérarnau B; Mercier P; Lemonnier FA
Eur J Immunol; 1990 Apr; 20(4):759-64. PubMed ID: 2189736
[TBL] [Abstract][Full Text] [Related]
35. Varying expression of major histocompatibility complex antigens on human renal endothelium and epithelium.
Evans PR; Trickett LP; Smith JL; MacIver AG; Tate D; Slapak M
Br J Exp Pathol; 1985 Feb; 66(1):79-87. PubMed ID: 3855644
[TBL] [Abstract][Full Text] [Related]
36. Production and characterization of xenogeneic antisera to a human renal cell carcinoma-associated antigen.
Ghose T; Belitsky P; Tai J; Janigan DT
J Natl Cancer Inst; 1979 Aug; 63(2):301-8. PubMed ID: 88535
[TBL] [Abstract][Full Text] [Related]
37. Expression of the human nephron differentiation molecules in renal cell carcinomas.
Droz D; Zachar D; Charbit L; Gogusev J; Chrétein Y; Iris L
Am J Pathol; 1990 Oct; 137(4):895-905. PubMed ID: 1699423
[TBL] [Abstract][Full Text] [Related]
38. Regional heterogeneity and complementation in the expression of the tumor-associated glycoprotein 72 epitopes in colorectal cancer.
Muraro R; Frati L; Bei R; Ficari F; Valli C; French D; Mammarella S; Caramia F; Fegiz G; Mariani-Costantini R
Cancer Res; 1991 Oct; 51(19):5378-83. PubMed ID: 1717150
[TBL] [Abstract][Full Text] [Related]
39. Metastatic spread and "escape" from the immune defenses of the host.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
[TBL] [Abstract][Full Text] [Related]
40. Regulation of HLA class I gene expression in human colorectal carcinoma.
Soong TW; Oei AA; Hui KM
Semin Cancer Biol; 1991 Feb; 2(1):23-33. PubMed ID: 1912515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
